BIR Annual Congress 2021

4th - 5th November 2021   (GMT+00:00) GMT

Up to 18 CPD credits available

Taking place on Thursday 4 November from 08:45-17:30 and Friday 5 November from 09:00-17:30

BIR Annual Congress 2021 
Working across boundaries for excellence

With a record number of delegates in 2018 and 2019 as well as during the pandemic in 2020, The BIR Annual Congress continues to get even BIGGER and BETTER in 2021!

Currently being delivered as an in-person conference with live online streaming elements. Should there be any changes to the government guidelines the event will be delivered virtually.

A mix of six different streams and seven topics offering a comprehensive programme on the latest innovations in imaging and treatment to medical imaging professionals and their senior management teams.

Taking place over two days, the event provides excellent opportunities to learn, interact and engage with attendees, speakers and industry representatives. There will also be plenty of opportunities to ask questions.

View Congress programme

Day one (Thursday 4 November)
  • Stream A: Musculoskeletal with trauma
  • Stream B: Artificial intelligence
  • Stream C: Therapeutic oncology
Day two (Friday 5 November)
  • Stream A: Leadership and wellbeing (AM) / Radiation issues for the frontline staff (PM)
  • Stream B: Incidentalomas with incidental findings
  • Stream C: Learning from experts and errors

Key note speakers
  • The Sir Godfrey Hounsfield award lecture by Professor Vicky Goh, King's College London
  • The Canon Mayneord lecture by Professor Clive Kay, King's College Hospital NHS Foundation Trust
Along with these exciting streams, we have interactive sessions with challenging cases followed by Q&A for further engagement.

Who should attend?

Anyone with an interest and passion for radiology, radiation oncology and the underlying sciences, including radiologists, physicists, radiographers, oncologists, physicians, radiation protection advisers and supervisors.

Call for abstracts
The BIR Annual Congress programme organisers welcome your abstracts for ePoster and video presentation relating to all areas of medical imaging and radiotherapy including educational case reports, audits and research. 

Our new poster and clips platform will allow you to display your ePoster or multimedia submission as an online resource for people to view your work before, during and after the event.

Abstract submissions will be open for two weeks from 7 June 10:00 BST until 21 June 24:00 BST. Abstracts submitted after the deadline will not be accepted.

Please note: We will only accept one abstract submission per presenting author. If you wish to submit any further abstracts, these will only be considered if you are a co-author and the presenting author is registered for the event.

Submission directions: To submit your abstract you will need to have a free user MyBIR portal set up. Please login or create one here. If you are already logged into your MyBIR, you can find the abstract submission form under the 'Education' tab at the top of the page once logged in and select the 'Submit abstracts/ePosters' button to go to the submission platform.

Sponsorship opportunities

To secure sponsorship at the congress, please contact us at

Registration fees:
BIR Plan 1 member: £185
BIR Plan 2 / Trainee / International member: £160
BIR Retired / Student member: £130
Non-member: £275
BIR Plan 1 member: £295
BIR Plan 2 / Trainee / International member: £250
BIR Retired / Student member: £200
Non-member: £420

BIR Plan 1 member: £215
BIR Plan 2 / Trainee / International member: £180
BIR Retired / Student member: £150
Non-member: £320
BIR Plan 1 member: £340
BIR Plan 2 / Trainee / International member: £290
BIR Retired / Student member: £230
Non-member: £495

Delegates are welcome to attend this year's Annual Congress virtually as it will be delivered as both face-to-face and live streamed event. If attending virtually, you will be required to purchase the full event and VAT (dependent on country you reside in) will be added when you register. If you wish to attend virtually, please complete the event registration form and return it to us at 

*Early bird rates expire on Sunday 5 September 2021

Registration information
Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees, we advise them to fill out the event registration form and return to Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email




We are very grateful to the following organisations for supporting this event.

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:


Aidence rallies the brightest minds in deep learning and radiology to create Veye Chest, an AI-based assistant for lung nodules on chest CT. Cutting through the hype around AI, we bring applications that add value for radiologists. Veye Chest is currently running in Lung Health Checks pilot sites and in routine practice across the UK.


Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999


contextflow empowers radiologists to complete their daily workload faster and with higher quality and cost-efficiency by delivering a unique and scalable AI backbone that fully integrates into clinical workflows. Its core technology includes SEARCH, a 3D image-based search engine, which provides relevant statistics, reference cases and differential diagnosis information at the point of care within seconds. It currently supports 18+ disease patterns in lung CTs, including those related to COVID-19. TRIAGE is a separate tool that allows radiologists to reorder their worklist based on the presence of specific or time-critical findings. All contextflow products are developed in close collaboration with practicing radiologists and thus integrate directly into your RIS/PACS. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. It was founded by a team of AI and engineering experts in July 2016. It is currently testing its software with 10+ partner hospitals and clinics throughout Europe. contextflow: See beyond a single case.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.


NeoDynamics AB (publ) is a Swedish Med Tech Company dedicated to advancing diagnosis and care of breast cancer. The company has developed an innovative precision biopsy system called NeoNavia. The NeoNavia system was developed based on research at the Karolinska Institutet in Sweden where patented “Pulse” technology was found to be beneficial in improving outcomes for biopsy procedures, namely, offering clinicians and patients accurate lesion targeting and high tissue yield, aiding correct diagnosis and individualized treatment. NeoNavia is currently being evaluated at leading clinics in UK as part of the COMPULSE study. We at Neodynamics want to contribute to better diagnostic methods for the millions of women in the world who suffer from breast cancer each year, thereby increasing the chances of survival. Anna Eriksrud, CEO.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit